Concepedia

Author

Yolanda Armero

Universitat de Barcelona

Also Known As

Juan Ambrosioni, Manuel Almela, Y. Armero, Yolanda Armero

25

Publications

1.3K

Citations

18

H-Index

24

Concepts

All Affiliations

Universitat de BarcelonaConsorci Institut D'Investigacions Biomediques August Pi I SunyerUniversitat Autònoma de BarcelonaBarcelona Centre for International AffairsHospital Clínic de Barcelona
YA

About

Yolanda Armero is an author at Universitat de Barcelona specializing in medicine, health sciences, and infection control.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

266

2

Health Sciences

5

5

248

3

Microbiology

2

2

110

4

Epidemiology

1

1

27

5

Hepatology

1

1

18

Yolanda Armero

×

18

Publications

1K

Citations

15

H-Index

YearCitations

Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis

Lawrence P. Park, Vivian H. Chu, Gail Peterson,

Journal of the American Heart Association

2016

199

High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis

José M. Miró, José M. Entenza, Ana del Rı́o,

Antimicrobial Agents and Chemotherapy

2012

123

Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone

Juan M. Pericàs, Carlos Cervera, Asunción Moreno,

Clinical Microbiology and Infection

2014

97

Efficacy and Safety of Fosfomycin Plus Imipenem as Rescue Therapy for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Multicenter Clinical Trial

Ana del Río Lechuga, Oriol Gasch, Asunción Moreno,

Clinical Infectious Diseases

2014

87

Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate <i>Staphylococcus epidermidis</i>

C. García-de-la-Mària, Francesc Marco, Yolanda Armero,

Antimicrobial Agents and Chemotherapy

2010

68

Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant <i>Staphylococcus aureus</i>

J. M. Miró, C. García-de-la-Mària, Yolanda Armero,

Antimicrobial Agents and Chemotherapy

2009

66

Effect of Vancomycin Minimal Inhibitory Concentration on the Outcome of Methicillin-Susceptible Staphylococcus aureus Endocarditis

Carlos Cervera, Ximena Castañeda, Cristina García de la Mària,

Clinical Infectious Diseases

2014

63

Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate <i>Staphylococcus aureus</i>

Francesc Marco, Cristina García de la Mària, Yolanda Armero,

Antimicrobial Agents and Chemotherapy

2008

57

Early <i>In Vitro</i> and <i>In Vivo</i> Development of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to Daptomycin

C. García-de-la-Mària, Juan M. Pericàs, Ana del Rı́o,

Antimicrobial Agents and Chemotherapy

2013

56

The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis

C. García-de-la-Mària, Oriol Gasch, Javier García‐González,

Antimicrobial Agents and Chemotherapy

2018

56

Page 1